Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ Human IL-18 R beta/IL-1 R7 Fc Chimera Recombinant Protein

Manufacturer:  R&D Systems™ 118AP100

Catalog No. 118AP100


Add to cart

Description

Description

Measured by its ability to inhibit the IL-18-induced response of KG-1 human acute myelogenous leukemia cells in the presence of soluble Recombinant Human IL-18 R alpha/IL-1 R5 Fc Chimera (Catalog # 816-LR ). The ED 50 for this effect is 2-6 µg/mL in the presence of 30 µg/mL of soluble IL-18 R alpha/Fc Chimera and 40 ng/mL of human IL-18.
Specifications

Specifications

Lyophilized from a 0.2μm filtered solution in PBS.
65.1 kDa (monomer)
90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
NS0
Disulfide-linked homodimer
Yes
8807
IL-18 R beta/IL-1 R7 Fc Chimera
100μg
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
Unlabeled
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit